Navigation Links
Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain
Date:5/12/2008

SCHAUMBURG, Ill., May 12 /PRNewswire-USNewswire/ -- The American Veterinary Medical Association (AVMA) has revised its policy on castration and dehorning of cattle to provide veterinarians with additional guidance for managing pain associated with these procedures. The revised policy, approved on April 12, 2008, does not dictate that practitioners use any particular method of pain management or drug. Instead it provides some basic recommendations for consideration by practitioners when they work with producers to achieve the goal of pain management.

Revisions made to the policy are the result of a comprehensive review of recent science that has provided more information about identifying and ameliorating pain experienced by cattle during castration and dehorning.

"Individual practitioners are encouraged to achieve pain management, when possible, using their education, experience and judgment," says Dr. Gail Golab, director of the AVMA Animal Welfare Division. "Administration of appropriate medications is one potential strategy; however, effective pain control does not always require the use of medications. It is also possible to mitigate pain by selecting a better technique or by applying a technique at a more appropriate age."

According to Dr. James Reynolds, a member of the AVMA Animal Welfare Committee and a bovine practitioner, the revised policy specifically respects the ability of veterinarians to determine the best way to mitigate pain in their patients on a case-by-case basis.

"The AVMA is not trying to dictate medical procedures, but it is the role of the AVMA to advise veterinarians on contemporary research," explains Dr. Reynolds. "With respect to dehorning and castration, current research supports this revised policy."

Dr. Reynolds reiterated that the revised policy does not suggest that pain medications must be used. For example, disbudding cattle within the first few weeks of life reduces pain compared with rem
'/>"/>

SOURCE American Veterinary Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
2. Chest Compressions Key to Revised CPR Guidelines
3. Schedules Revised for Flu, Meningitis Vaccines
4. Mayo researchers say ECG standards should be revised for elderly
5. Mayo Researchers Say ECG Standards Should Be Revised for Elderly
6. USP announces revised glycerin monograph
7. QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index (As Revised)
8. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
9. Chinas 1-child policy could backfire on its elderly
10. Education Key Focus of Michigan Policy Summit
11. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
(Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The New ... and lyrical music, will be performed by the award-winning ... Estates, CA, this March 6-22, 2015, on Fridays, Saturdays ... at Peninsula High School (27118 Silver Spur Road, ... hour before the program or may be purchased on-line ...
(Date:3/4/2015)... 2015 The report covers spices ... marketing channels, industry development trend and proposals. The ... including spices definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3
... Speaker Nancy Pelosi issued the following statement today ... Prevention and Tobacco Control Act, which gives the Food ... and marketing. , , "Today, President Obama ... making America healthier. This bipartisan legislation grants the FDA ...
... Park Targets Pittsburgh Children ... United Concordia Dental and the Pittsburgh Pirates organization began several years ago, ... community as Pennsylvanians and the nation struggle with the uncertainty of a ... will team up from 4 to 7 p.m. Monday June 29 at ...
... disorder marked in part by auditory hallucinations and paranoia, can ... when people are ready to stand on their own two ... scientists at UCLA think they are beginning to understand one ... its kind, the researchers used a novel form of brain ...
... MARINO, Calif., June 22 Epeius Biotechnologies ( ... with a dramatic demonstration of single-agent efficacy with its ... (accessible online as of June 16, 2009 in Molecular ... Gene Therapy, www.nature.com/mt/ ) documents the ...
... Washington, D.C.-based law firm of Schmidt & Clark, LLP ... the U.S. Food and Drug Administration where ... Inc. (NYSE: ABT ) failed to disclose multiple reports ... , , In an Associated Press story reported June 20, ...
... , HARBIN, China, June 22 ... Medical" or "the Company") (Nasdaq: CSKI ), ... People,s Republic of China ("PRC"), today announced that it,obtained ... proprietary Sumei,Slim Patch from Heilongjiang Provincial FDA, which will ...
Cached Medicine News:Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 2Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 3Health News:Alterations in brain's white matter key to schizophrenia, UCLA study shows 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 3
(Date:3/4/2015)... ROCHESTER, Minn. , March 4, 2015   ... reached an agreement to develop the next generation of ... "We are hoping that this technology will be ... obesity and diabetes," says James Levine, M.D., Ph.D. ... researcher. "They are accurate, inexpensive, and can be integrated ...
(Date:3/4/2015)... PHILADELPHIA , March 4, 2015 ... be attending the 2015 Distribution Management Conference and ... This conference is HDMA,s largest supply chain education ... and third parties who keep the pharmaceutical distribution ... spotlight on regulatory and legislative issues important to ...
(Date:3/4/2015)... March 4, 2015 Following the reintroduction ... Action Center (LAC) released a report today urging ... opioid and heroin epidemic through more effective use ... report, "The Case for Expanding Access to Medication-Assisted ... outlines the health, justice, and economic advantages of ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2
... , March 11 Watson Pharmaceuticals, Inc. ... Food and Drug Administration (FDA) approval of TRELSTAR® 22.5 ... formulation of TRELSTAR®, a proven, simple and effective palliative ... launch, TRELSTAR® 22.5 mg is the first and only ...
... SiteJabber.com , a leading consumer protection service which helps people avoid fraudulent websites and find good sites, and LegitScript.com ... websites and avoid fraudulent ones. , ... ... ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 2SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 3
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: